Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Nov 12, 2024, after the close
10-Q filed Nov 12, 2024, 43 days after period end · 0000320017-24-000058
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | — |
| Net Income | -$4.93M | -$5.26M | -$37.38M | -$6.93M |
| EPS Diluted |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$0.59 |
| -$0.65 |
| -$7.88 |
| -$1.74 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
